ID

24050

Description

Study ID: 100716 Clinical Study ID: NKP100716 Study Title: An open label repeat dose study to investigate the effect of GW597599 (15 mg) and paroxetine (10 mg) given in combination for 15 days on the pharmacokinetics of midazolam and dextromethorphan in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: vestipitant Trade Name: paroxetine and vestipitant Study Indication: Depressive Disorder and Anxiety Disorders Documentation part: Pharmacogenetic Research, Prior And Concomitant Medication, Baseline Signs and Symptoms

Keywords

  1. 7/24/17 7/24/17 -
  2. 9/20/21 9/20/21 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 24, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Pharmacogenetic Research, Prior And Concomitant Medication, Baseline Signs And Symptoms

GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Pharmacogenetic Research, Prior And Concomitant Medication, Baseline Signs And Symptoms

Pharmacogenetic Research
Description

Pharmacogenetic Research

Alias
UMLS CUI-1
C0031325
Has informed consent been obtained for Pharmacogenetic Research?
Description

consent for pharmacogenetic research

Data type

boolean

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0021430
If Yes, record the date informed consent obtained for Pharmacogenetic Research
Description

consent for pharmacogenetic research date

Data type

date

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C0011008
If No, check one reason:
Description

consent for pharmacogenetic research reason

Data type

text

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C0392360
Specify other:
Description

consent for pharmacogenetic research reason

Data type

text

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C0392360
Has a blood sample been collected for Pharmacogenetic Research?
Description

blood sample collection

Data type

boolean

Alias
UMLS CUI [1]
C0005834
If Yes, record the date the sample was taken:
Description

blood sample collection date

Data type

date

Alias
UMLS CUI [1,1]
C0005834
UMLS CUI [1,2]
C0011008
Has this subject withdrwan consent for Pharmacogenetic Research?
Description

withdrawal of consent

Data type

boolean

Alias
UMLS CUI [1]
C1707492
Has a request been made for sample destruction?
Description

blood sample destruction

Data type

boolean

Alias
UMLS CUI [1,1]
C1948029
UMLS CUI [1,2]
C0178913
If Yes, check one reason:
Description

blood sample destruction reason

Data type

integer

Alias
UMLS CUI [1,1]
C1948029
UMLS CUI [1,2]
C0178913
UMLS CUI [1,3]
C0392360
Specify other:
Description

blood sample destruction reason

Data type

text

Alias
UMLS CUI [1,1]
C1948029
UMLS CUI [1,2]
C0178913
UMLS CUI [1,3]
C0392360
Prior Medication
Description

Prior Medication

Alias
UMLS CUI-1
C0013227
Has the subject taken any medication within 1 week PRIOR to the first dose of study medication?
Description

If Yes, please record the medications below.

Data type

boolean

Alias
UMLS CUI [1]
C0013227
Drug Name (Trade Name Preferred)
Description

drug name

Data type

text

Alias
UMLS CUI [1]
C0013227
Single Dose/Unit (e.g. 500mg)
Description

dosage

Data type

text

Alias
UMLS CUI [1]
C0178602
Frequency of this Dose (e.g. BID, PRN)
Description

frequency of this dose

Data type

text

Alias
UMLS CUI [1]
C3476109
Route
Description

administration route

Data type

text

Alias
UMLS CUI [1]
C0013153
Indication
Description

medication indication

Data type

text

Alias
UMLS CUI [1]
C3146298
Duration of Therapy (e.g. 6 years)
Description

duration of therapy

Data type

text

Alias
UMLS CUI [1]
C0444917
End Date
Description

medication end date

Data type

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0013227
Continuing at end of study?
Description

continuing medication at end of study

Data type

boolean

Alias
UMLS CUI [1]
C1553904
Baseline Signs Ans Symptoms
Description

Baseline Signs Ans Symptoms

Alias
UMLS CUI-1
C0037088
UMLS CUI-2
C1442488
Baseline Sign/Symptom
Description

diagnosis

Data type

text

Alias
UMLS CUI [1]
C0011900
Onset Date and Time
Description

onset date and time

Data type

datetime

Alias
UMLS CUI [1,1]
C2981441
UMLS CUI [1,2]
C1442488
End Date and Time
Description

end date and time

Data type

datetime

Alias
UMLS CUI [1,1]
C2981425
UMLS CUI [1,2]
C1442488
Outcome (If yubject dies, please inform GSK within 24 hours and complete form D)
Description

outcome

Data type

text

Alias
UMLS CUI [1]
C1705586
Event Course
Description

event course

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0750729
Intensity
Description

intensity

Data type

text

Alias
UMLS CUI [1]
C0518690
Relationship to study procedures performed prior to randomisation
Description

relationship to study procedures

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C1510821
Corrective Therapy
Description

If Yes, please record on Prior Medication form.

Data type

boolean

Alias
UMLS CUI [1,1]
C0559546
UMLS CUI [1,2]
C0087111
Was subject withdrawn due to this event?
Description

subject withdrawn due to event

Data type

boolean

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0877248

Similar models

GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Pharmacogenetic Research, Prior And Concomitant Medication, Baseline Signs And Symptoms

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Pharmacogenetic Research
C0031325 (UMLS CUI-1)
consent for pharmacogenetic research
Item
Has informed consent been obtained for Pharmacogenetic Research?
boolean
C0031325 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
consent for pharmacogenetic research date
Item
If Yes, record the date informed consent obtained for Pharmacogenetic Research
date
C0031325 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item
If No, check one reason:
text
C0031325 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Code List
If No, check one reason:
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other (0)
consent for pharmacogenetic research reason
Item
Specify other:
text
C0031325 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
blood sample collection
Item
Has a blood sample been collected for Pharmacogenetic Research?
boolean
C0005834 (UMLS CUI [1])
blood sample collection date
Item
If Yes, record the date the sample was taken:
date
C0005834 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
withdrawal of consent
Item
Has this subject withdrwan consent for Pharmacogenetic Research?
boolean
C1707492 (UMLS CUI [1])
blood sample destruction
Item
Has a request been made for sample destruction?
boolean
C1948029 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
Item
If Yes, check one reason:
integer
C1948029 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Code List
If Yes, check one reason:
CL Item
Subject requested (1)
CL Item
Screen failure (2)
CL Item
Other (0)
blood sample destruction reason
Item
Specify other:
text
C1948029 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Item Group
Prior Medication
C0013227 (UMLS CUI-1)
prior medication
Item
Has the subject taken any medication within 1 week PRIOR to the first dose of study medication?
boolean
C0013227 (UMLS CUI [1])
drug name
Item
Drug Name (Trade Name Preferred)
text
C0013227 (UMLS CUI [1])
dosage
Item
Single Dose/Unit (e.g. 500mg)
text
C0178602 (UMLS CUI [1])
frequency of this dose
Item
Frequency of this Dose (e.g. BID, PRN)
text
C3476109 (UMLS CUI [1])
administration route
Item
Route
text
C0013153 (UMLS CUI [1])
medication indication
Item
Indication
text
C3146298 (UMLS CUI [1])
duration of therapy
Item
Duration of Therapy (e.g. 6 years)
text
C0444917 (UMLS CUI [1])
medication end date
Item
End Date
date
C0806020 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
continuing medication at end of study
Item
Continuing at end of study?
boolean
C1553904 (UMLS CUI [1])
Item Group
Baseline Signs Ans Symptoms
C0037088 (UMLS CUI-1)
C1442488 (UMLS CUI-2)
diagnosis
Item
Baseline Sign/Symptom
text
C0011900 (UMLS CUI [1])
onset date and time
Item
Onset Date and Time
datetime
C2981441 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
end date and time
Item
End Date and Time
datetime
C2981425 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
Item
Outcome (If yubject dies, please inform GSK within 24 hours and complete form D)
text
C1705586 (UMLS CUI [1])
Code List
Outcome (If yubject dies, please inform GSK within 24 hours and complete form D)
CL Item
Resolved (Resolved)
CL Item
Ongoing (Ongoing)
CL Item
Died (Died)
Item
Event Course
text
C0877248 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Code List
Event Course
CL Item
Intermittent (Intermittent)
CL Item
Constant (Constant)
Item
Intensity
text
C0518690 (UMLS CUI [1])
Code List
Intensity
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
Item
Relationship to study procedures performed prior to randomisation
text
C0877248 (UMLS CUI [1,1])
C1510821 (UMLS CUI [1,2])
Code List
Relationship to study procedures performed prior to randomisation
CL Item
Not related (Not related)
CL Item
Unlikely (Unlikely)
CL Item
Suspected (Suspected)
CL Item
Probable (Probable)
corrective therapy
Item
Corrective Therapy
boolean
C0559546 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
subject withdrawn due to event
Item
Was subject withdrawn due to this event?
boolean
C0422727 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial